General MedicationsORALGeneric

ACTOPLUS MET XR

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Standard Dose

1GM;EQ 30MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview ACTOPLUS MET XR is listed in Drugs@FDA under application 022024 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2017-12-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACTOPLUS MET XR is listed in Drugs@FDA under application 022024 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2017-12-21 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.